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Introduction
Podosomes are a distinctive form of integrin-mediated cell- 
matrix adhesion typical of monocyte-derived cells but under 
some circumstances produced by cells of other lineages. They 
usually appear as micrometer-sized radially symmetrical pro-
trusions containing central actin cores (height ∼2 µm) rooted 
in the cytoplasm surrounded by matrix-associated “adhesive 
rings” (∼1-µm diameter) enriched in integrins and plaque pro-
teins such as talin, paxillin, vinculin, and Tks5 (Calle et al., 
2006; Wiesner et al., 2010; Murphy and Courtneidge, 2011; Cox 
and Jones, 2013; Labernadie et al., 2014; Meddens et al., 2014; 
Seano et al., 2014). In the majority of cell types, podosomes 
form arrays consisting of numerous individual podosomes con-
nected to each other via a mesh of F-actin–containing links 
containing myosin-II (Cox et al., 2011; van den Dries et al., 
2013; Panzer et al., 2016). Individual podosome-like structures 
formed by invasive cancer cells are more stable, protrusive, and 
larger in size than normal podosomes and are often termed inva-
dopodia (Gimona et al., 2008; Murphy and Courtneidge, 2011). 
Podosomes participate in the processes of cell migration and 
invasion as well as degradation of ECM via secretion of matrix 
metalloproteinases (MMPs; Gawden-Bone et al., 2010; Wiesner 
et al., 2010; Linder and Wiesner, 2015; El Azzouzi et al., 2016).
Cells of monocytic origin (for example, cultured macro-
phage-like THP1 cells) form numerous podosomes upon stim-
ulation with TGFβ or increasing PKC activity by phorbol esters 
(e.g., PMA). Moreover, upon appropriate stimulation, even 
podosome-lacking cells can be forced to form podosome-like 
structures. In particular, expression of constitutively active Src 
in fibroblasts triggers formation of high-order adhesion struc-
tures termed podosome rosettes, which are capable of degrading 
the ECM (Tarone et al., 1985). More recently, we have shown 
that nontransformed fibroblasts that typically do not form po-
dosomes develop podosome-like adhesions under conditions in 
which a cell cannot apply strong traction force to nascent inte-
grin clusters, such as spreading on fluid arginylglycylaspartic 
acid (RGD)–functionalized lipid bilayers, where stress fibers 
fail to assemble (Yu et al., 2013).
A key process in podosome formation is a local polym-
erization of actin cores primarily mediated by Arp2/3 com-
plex activated by Wiskott–Aldrich syndrome protein (WASP; 
Machesky and Insall, 1998; Linder et al., 1999; Burns et al., 
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2001). In turn, WASP activation depends largely on the ac-
tivity of the small G protein Cdc42 and can be regulated by 
WASP-interacting protein (WIP; Abdul-Manan et al., 1999; 
Calle et al., 2004; Monypenny et al., 2011; Schachtner et al., 
2013; Vijayakumar et al., 2015). Indeed, microinjection of 
dominant-negative Cdc42 has been shown to significantly im-
pair podosome formation in human dendritic cells (Burns et al., 
2001). Similarly, podosome formation is impaired in cells mi-
croinjected with dominant-negative Rac1 (Burns et al., 2001), 
as well as in Rac1- and especially Rac2-depleted cells (Wheeler 
et al., 2006), although the downstream pathways are not yet 
elucidated. Conversely, active RhoA, which typically promotes 
assembly of stress fibers and focal adhesions, has been gener-
ally described to be low in podosome-forming cells (Pan et al., 
2011; Yu et al., 2013), and microinjection of active RhoA im-
pairs podosome formation (Burns et al., 2001).
Although the role of Rho family GTPases in podosome 
formation is relatively well documented, the function of the 
ARF family of G proteins is essentially unknown. Even though 
these proteins are considered mainly as regulators of mem-
brane traffic, some evidence exists that they also participate 
in a variety of processes related to regulation of the actin cy-
toskeleton and involved in cross talk with the G proteins of 
the Rho family. In particular, ARF1, the most abundant ARF 
family member, known to recruit the coatomer complexes for 
vesicle budding in the Golgi (Donaldson and Jackson, 2011), 
was shown to be required for clathrin-independent endocytosis 
(Kumari and Mayor, 2008), as well as for formation of “ven-
tral actin structures” in some cell types (Caviston et al., 2014). 
Thus ARF1 is a potentially interesting candidate for function 
as a podosome regulator because it could control fundamental 
systems involved in podosome formation, actin cytoskeleton, 
and the plasma membrane.
In this study, we demonstrate that regardless of particular 
stimuli, ARF1 is required for inducing podosome formation in 
different cell types. Moreover, these stimuli, via an ARF ex-
change factor, ARNO, increase the fraction of GTP-bound ARF1 
in cells. ARNO localizes to the adhesive ring of podosomes, and 
its inhibition interferes with podosome assembly. We demon-
strate that the ARNO-ARF1 pathway regulates podosomes by 
inhibition of RhoA- and ROCK-dependent formation of myo-
sin-II filaments, which antagonizes podosome integrity. In addi-
tion, constitutively active ARF1 induces formation of actin-rich 
puncta colocalizing with matrix degradation sites and containing 
podosome core markers. Our data strongly suggest a direct role 
for ARF1 in podosome-type adhesions and further extend the 
increasing number of roles for ARF1 at the plasma membrane.
Results
Depletion of endogenous ARF1 interferes 
with podosome formation
Stimulation by either TGFβ1 or the PKC activator, PMA, has 
been previously used as a model system to study podosome for-
mation and dynamics in several cell types (Tatin et al., 2006; 
Varon et al., 2006; Burger et al., 2011; Monypenny et al., 2011). 
Consistent with numerous previous studies, we define podo-
somes as F-actin–rich spots with a diameter of ∼0.5 µm sur-
rounded by an approximately ring-shaped vinculin-rich zone. 
We consider a cell as “podosome-forming” if it has more than 
10 morphologically identifiable podosomes.
In this study, 85 ± 4.7% (mean ± SD, n = 3 indepen-
dent experiments) of cells of the human monocytic cell line, 
THP1, plated on fibronectin-coated substrata in the presence of 
TGFβ1, formed podosomes after 24 h, with 55 ± 3.2 (mean ± 
SEM, n = 212 cells) podosomes per cell. The corresponding 
numbers for PMA-stimulated cells were 88 ± 5.5% and 140 ± 
19.5 (n = 80 cells), respectively. For cells plated on fibronec-
tin in the absence of any additional stimuli, the percentage of 
podosome-forming cells was only 15 ± 4.7% (n = 3 independent 
experiments), and even among these cells, the mean number of 
podosomes did not exceed 22 ± 8.7 (n = 58 cells).
To investigate the role of ARF1 in podosome dynamics, 
we depleted ARF1 in TGFβ1-treated THP1 cells by siRNA. Im-
mediately before plating, cells were electroporated with ARF1 
or control siRNA and seeded onto fibronectin in the presence 
of TGFβ1. We observed that maximum silencing (>95%) was 
achieved by 48 h (Fig. 1 A).
Depletion of ARF1 led to a dramatic decrease of podo-
some number in TGFβ1-treated cells (Fig. 1, B and C). Both 
the number of podosomes per cell and the percentage of po-
dosome-forming cells significantly dropped upon ARF1 deple-
tion (Fig. 1, D–F). Although the mean number of podosomes 
per cell and the percentage of podosome-forming cells in cells 
transfected with control siRNA did not differ from aforemen-
tioned control numbers, the cells transfected with ARF1 siRNA 
had a mean of only 8 ± 1.7 (n = 96 cells) podosomes per cell. 
Total intensity of F-actin–containing nonpodosomal structures 
at the ventral surface of the cells became somewhat higher in 
ARF1-depleted cells (Fig. 1, B and C, left). At the same time, 
the vinculin-containing nonpodosomal structures at the cell pe-
riphery that can be classified as small focal adhesions were not 
apparently affected (Fig. 1, B and C, right). Depletion of ARF1 
by siRNA did not affect the integrity of the Golgi apparatus 
as visualized by cis-Golgi markers GM130/GRA SP65 (Fig. 1, 
B and C), in agreement with previous publications (Volpicelli- 
Daley et al., 2005; Szul et al., 2007; Nakai et al., 2013).
The effect of ARF1 siRNA on podosome number was 
specific because it could be fully reversed by expression of ex-
ogenous bovine HA-ARF1 insensitive to human ARF1 siRNA 
(Fig.  1, D–F). Interestingly, exogenous HA-ARF1 was often 
localized in the spots adjacent to the podosomes of trans-
fected cells (Fig. 1 D, right). See Fig. 2 for a detailed analysis 
of localization dynamics. Significantly, we found that loss of 
podosome induction caused by ARF1 depletion was not ex-
clusive to TGFβ1 stimulation, because after PMA stimulation 
(Fig. S1, A–I), ARF1-depleted cells demonstrated a significant 
decrease in both the number of podosomes and the percent-
age of podosome-forming cells compared with control cells 
(Fig. S1, A, D, F, and G).
In contrast to ARF1, depletion of ARF6 by siRNA with 
a silencing efficiency of >95% (Fig. S1 J) did not affect po-
dosome induction in TGFβ1-treated THP1 cells (Fig. S2 K). 
Neither the mean number of podosomes per cell nor the per-
centage of cells forming more than 10 podosomes was signifi-
cantly different from control siRNA-treated cells (Fig. 1, E and 
F). Collectively, these data indicate a specific role for ARF1 in 
podosome induction in stimulated THP1 cells.
We also examined the effect of expression of domi-
nant-negative and constitutively active mutants of ARF1 on 
adhesion of THP1 cells in the presence of TGFβ1. The dom-
inant-negative mutant, CFP-ARF1 (T31N), led to a significant 
decrease of cell adhesion to fibronectin under these conditions 
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Figure 1. Depletion of endogenous ARF1 disrupts podosomes. (A) Western blot showing ARF1 levels in cells treated with scrambled (control) or ARF1 
siRNA; α-tubulin was used as a loading control. (B and C) ARF1 knockdown leads to disruption of podosomes but not the Golgi apparatus. Actin labeled 
with phalloidin (left) and vinculin visualized by antibody staining (right) in control (B) and ARF1 siRNA-transfected (C) THP1 cells 48 h after TGFβ1 stimula-
tion. The Golgi apparatus in the same cells was visualized by staining with antibody against cis-Golgi proteins, GM130 (left, green) and GRA SP65 (right, 
red). Bars, 5 µm. (D) Expression of HA-tagged bovine ARF1 in ARF1-depleted human THP1 cells rescues podosome formation. Podosomes are visualized 
by phalloidin staining (left) and HA-ARF1 by immunostaining with anti-HA antibody (middle); merged image is shown on the right. Bar, 5 µm. HA-ARF1 
was localized to Golgi and to punctate structures shown with high magnification in the right panels representing the enlarged area boxed to the left. Bar, 
1 µm. Labeling in the right panel of D shows actin (top), HA-ARF1 (middle), and merged image of both (bottom). Width of the images is 7 µm. (E and F) 
Quantification of the effect of ARF1 and ARF6 knockdown on podosome integrity. Both number of podosomes per cell (E) and percentage of cells having 
more than 10 podosomes (F) decreased upon ARF1 but not ARF6 knockdown. Mean ± SD is indicated.This effect was rescued by expression of exogenous 
HA-ARF1. The graphs represent results of three independent experiments with 100–200 cells used for each group. The numbers of podosomes per cell 
are presented as a box-and-whiskers plot. Values of median, lower and upper quartiles (box), minimum and maximum values (whiskers) are indicated. 
The percentages of cells with more than 10 podosomes are presented as mean ± SD. The significance of the difference between groups was estimated by 
two-tailed Student’s t test. ns, P > 0.05 (nonsignificant); **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001.
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(control: 71 ± 5.5%; ARF1 T31N: 4 ± 0.3%), and the few ad-
herent cells observed did not form podosomes (unpublished 
data). This behavior resembles a “non-adhesive phenotype,” 
described previously in the culture of normal human dendritic 
cells (Burns et al., 2004). Unexpectedly, the expression of a 
constitutively active mutant of ARF1, CFP-ARF1 (Q71L), also 
interfered with cell adhesion and completely prevented podo-
some formation. Thus, sustained high activity of ARF1 is also 
damaging for cell adhesion and podosome formation in THP1 
cells. Overexpression of wild-type ARF1 or constitutively ac-
tive ARF1 in unstimulated THP1 cells did not induce any ap-
parent phenotypic changes. These cells remain poorly attached 
to the fibronectin and do not form podosomes.
ARF1-containing vesicles transiently 
contact podosomes
We used fluorescently tagged ARF1 to further elucidate the lo-
calization and dynamics of ARF1 in TGFβ1-stimulated THP-1 
cells. Expression of GFP-ARF1 showed a predominant Golgi 
localization (Fig. 1 D) in agreement with previous publications 
(Lippincott-Schwartz et al., 1989; Sciaky et al., 1997). How-
ever, in addition to the Golgi localization, we found numerous 
irregular puncta throughout the cell, some of which were ap-
parently associated with podosomes (Figs. 1 D [right] and 2 A).
We used total internal reflection fluorescence (TIRF) 
microscopy to explore the spatiotemporal dynamics of ARF1 
puncta at the plasma membrane. GFP-ARF1 puncta displayed 
temporal localization at regions of podosome assemblies and 
made transient periodic contacts with the adhesive rings of 
podosomes, as marked by mCherry-vinculin in THP1 cells 
(Fig. 2 B and Video 1). Up to 80% of podosomes appeared to 
be in contact with ARF1-containing puncta during 5-min pe-
riods of observation (Fig. 2 C), with a mean dwell time of 10 
± 1.6 s (mean ± SEM; Fig. 2 D). In contrast, CFP-ARF6 does 
not form puncta-like structures in THP1 cells, and no pref-
erential localization of CFP-ARF6 to regions of podosome 
assembly was found (Fig. S1 L). We further characterized 
the GFP-ARF1–associated puncta by determining whether 
their mobility was dependent on a cytoskeletal network. We 
found that GFP-ARF1 patches appeared to be traveling on 
microtubule tracks identified by labeling with mCherry-ens-
consin (Fig. 2, E and F; and Video 2). To elucidate the nature 
of the ARF1 puncta, we coexpressed GFP-ARF1 with sev-
eral markers of vesicular traffic carriers, Rab6, Rab7, Rab8, 
and Rab11 (Fig. S2, A–D). Among those, Rab11 (Welz et 
al., 2014) demonstrated significant colocalization with 
ARF1 (Fig. S2 E), suggesting that ARF1-containing puncta 
have a vesicular nature.
Inhibition of ARF1 activity interferes 
with formation of podosomes induced by 
diverse stimuli
To study the immediate effect of ARF1 inhibition on podo-
some formation, we used two inhibitors known to suppress 
ARF1 activity. Brefeldin A (BFA) promotes formation of 
complexes between GDP-bound ARF1 and Sec7 domains of 
ARF1 nucleotide exchange factors GBF1, BIG1, and BIG2 
and prevents completion of the nucleotide exchange reaction 
(D’Souza-Schorey and Chavrier, 2006). SecinH3 inhibits activ-
ity of another group of ARF exchange factors, cytohesins 1–4, 
by binding to their Sec7 domain, without formation of a com-
plex with ARF1 (Casanova, 2007).
Using a G-LISA assay for the measurement of ARF1-
GTP levels, we demonstrate that TGFβ1 or PMA treatment of 
THP1 cells enhances the fraction of active, GTP-bound ARF1, 
whereas both SecinH3 and BFA significantly reduces it (Figs. 
3 A and S1 C). Both SecinH3 and BFA treatment induced rapid 
disassembly of all podosomes in ∼30–40 min (Fig. 3, B–F, and 
Video 3). In the case of SecinH3, this process was accompanied 
by a burst of lamellipodial activity (Fig. 3 B); the integrity of the 
Golgi apparatus was not affected, nor was localization of ARF1 
to Golgi and to vesicular structures in the cytoplasm (Fig.  3, 
B and C). Unlike SecinH3 treatment, disruption of podosomes 
with BFA was accompanied by loss of ARF1 localization at the 
Golgi and at cytoplasmic vesicular structures (Fig. 3 D), as well 
as structural disintegration of the Golgi apparatus, in agree-
ment with numerous previous studies (Lippincott-Schwartz et 
al., 1989; Donaldson et al., 2005). Thus, comparison between 
the SecinH3 and BFA effects confirmed that active ARF1 is re-
quired for podosome integrity, and this function of ARF1 does 
not depend on its role in Golgi stabilization. A second confir-
mation of independence of podosomes from Golgi traffic can 
be inferred from experiments with knockdown of COPB1, a 
subunit of the COPI coatomer protein complex required for ret-
rograde transport from trans-Golgi to cis-Golgi and ER (Beck 
et al., 2009). We found that COPB1 knockdown or its inhibition 
generated only minor effects on podosome integrity (Fig. S3, 
A–E). Finally, disruption of podosomes with SecinH3 or BFA 
still proceeded (albeit at a slower rate) in TGFβ1-stimulated 
THP1 cells expressing constitutively active Cdc42 (GFP–Cdc42 
Q61L), a potent podosome-inducing signaling protein (Fig. S3 
H). Moreover, treatment of cells with BFA or SecinH3, as well 
as knockdown of ARNO or ARF1, did not change the level of 
Cdc42-GTP in TGFβ-stimulated THP1 cells (Fig. S3, I and J).
Visualization of podosomes using structured-illumination 
microscopy (SIM) revealed a central F-actin core surrounded 
by patches enriched in adhesion proteins (talin and vinculin) 
as well as thin F-actin–rich links connecting neighboring po-
dosomes (Fig. S4 A and Video 4) in agreement with previous 
studies (Cox et al., 2011; van den Dries et al., 2013). Treatment 
with SecinH3 led to the rapid disappearance of the connecting 
links and gradual concurrent disassembly of both the actin cores 
and surrounding adhesive rings (Fig. S4, B and C; and Video 5).
In view of the high podosome turnover rate (van den Dries 
et al., 2013), gradual disruption of podosomes upon addition 
of SecinH3 suggests that inactivation of ARF1 changes the 
balance between podosome assembly and disassembly rather 
than completely blocking the assembly processes. The process 
of disassembly often proceeds through podosome fission and is 
accompanied by an apparent increase of podosome mobility in 
the plane of the plasma membrane (Fig. S4, D–F).
We next studied the effect of inhibition of ARF1 on 
podosome-like structures formed by fibroblast-type cells. 
Under standard culture conditions, mouse embryonic fibro-
blasts (MEFs) generally form focal adhesions, which appeared 
to be resistant to treatment with either BFA (Bershadsky and 
Futerman, 1994) or SecinH3 (Fig. S5 A). It was recently 
shown that fibroblasts plated on a fluid substratum (supported 
RGD-functionalized lipid bilayer), under conditions where 
they cannot exert traction forces, by default formed podo-
some-like adhesion structures (Yu et al., 2013). We showed 
that the level of GTP-ARF1 increased in MEFs plated on 
supported lipid bilayers (Fig. 3 G). Similarly to classic podo-
somes, podosome-like structures formed by MEFs plated on 
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Figure 2. Localization and dynamics of ARF1 puncta in TGFβ1-stimulated THP1 cells. (A) TIRF image of the ventral surface of cell with podosomes labeled 
by mCherry-vinculin (left) and ARF1 puncta labeled by GFP-ARF1 (middle). Merged image (right) shows nonrandom distribution of ARF1 puncta with a 
tendency to colocalize to podosome periphery (see white arrowheads). Bar, 5 µm. Boxed area (2.5 × 2.5 µm2) contains a podosome whose colocalization 
dynamics with ARF1 puncta is presented in B. (B, left) Kymograph representing fluorescent intensities in a line scan through the podosome boxed in A. Al-
though mCherry-vinculin is stably labeled in the podosome ring (top), GFP-ARF1 was transiently concentrated at one side of the ring (middle, merged image 
at bottom). See also Video 1. (B, right) The time course of fluorescence intensity of GFP-ARF1 at the podosome ring. (C) Each dot corresponds to a single 
cell and represents percentage of podosome rings (labeled by vinculin) contacted by either ARF1-containing puncta or Rab6-containing vesicles within 5 
min of image acquisition. Mean ± SD is indicated. (D) Frequency distribution of the durations of podosome contacts (in seconds) with ARF1-containing 
puncta (35 podosomes from 10 cells were filmed as shown in kymograph B). (E and F) GFP-ARF1 puncta moving along microtubules. (E) Left, microtubule 
labeling with 125-kD microtubule-associated protein, ensconsin (mCherry-ensconsin); middle, GFP-ARF1 puncta in the same cell; right, merged image. The 
dynamics of microtubules and ARF1 puncta in the boxed area (8 × 7.5 µm2) of C is shown in F. Bars, 5 µm. Movement of puncta along the microtubule is 
indicated by the arrowhead. See also Video 2.
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Figure 3. ARF1-GTP levels and podosome formation. (A) Quantification of ARF1-GTP levels by G-LISA assay in control, stimulated, and inhibitor-treated 
THP1 cells. Both TGFβ1 and PMA increased the fraction of GTP-bound ARF1 compared with control, whereas treatment with SecinH3 or BFA dramatically 
reduced it. Pooled results of three independent experiments are shown. Mean ± SD is indicated. (B) Disruption of podosomes labeled with mCherry-Utro-
phin (UtrCH) upon treatment with SecinH3 (top). Note that integrity of the Golgi apparatus labeled with GFP-mannosidase II was preserved in the same 
SecinH3-treated cell (bottom). See also Video 3. (C and D) Disruption of podosomes labeled with mCherry-vinculin by SecinH3 (C, top) and BFA (D, top). 
Although the effect of SecinH3 in these cells was not accompanied by changes in localization of ARF1 to the Golgi and cytoplasmic puncta (C, bottom), 
BFA disrupted both Golgi and ARF1 puncta (D, bottom); Bars, 5 µm. Insets (1 × 1 µm2) show evolution of individual ARF1 puncta in each case. (E and 
F) Quantification of the effect of SecinH3 and BFA on number of podosomes per cell (E) and percentage of cells with more than 10 podosomes (F). 
(G) ARF1-GTP level increase in fibroblasts plated on a RGD-functionalized fluid lipid bilayer compared with fibroblasts plated on glass coverslip. Mean 
± SD is indicated. (H) Effect of SecinH3 on the integrity of podosome-like structures formed by fibroblasts plated on fluid lipid bilayer. (I) Quantification 
of the disruptive effect of SecinH3 and BFA on podosome-like structures formed by fibroblasts on lipid bilayer. The percentage of podosome-forming cells 
significantly decreased upon treatment by each of the inhibitors. The data in E, F, and I are presented as indicated in the legend to Fig. 1. Pooled data 
of three independent experiments are presented for each group. The significance of the difference between groups was estimated by two-tailed Student’s 
t test. ns, P > 0.05 (nonsignificant); *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001.
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the lipid bilayer underwent rapid disassembly upon treatment 
with either BFA or SecinH3 (Fig. 3, H and I).
A well-known method of induction of podosome-like 
structures in fibroblast-like cells is ectopic expression of consti-
tutively active Src. In agreement with published results (Tarone 
et al., 1985), expression of Src Y527F in MEFs led to the for-
mation of prominent rosettes formed as a result of fusion of nu-
merous podosome-like structures (Fig. S5, B and C). Treatment 
of such cells with either BFA or SecinH3 resulted in the gradual 
disassembly of these rosettes and a decrease in the number of 
rosette-positive cells (Fig. S5, B and C).
Altogether, these data demonstrate that ARF1 activity is 
required for formation/maintenance of podosome-like struc-
ture irrespective of upstream stimuli (TGFβ1, PMA, active 
Src, or fluid substratum). We conclude that a role for ARF1 in 
podosome dynamics is independent of early signaling path-
ways that lead to initiation of cellular differentiation to a podo-
some-generating phenotype.
ARNO guanine nucleotide exchange 
factor activates ARF1 to drive 
podosome formation
The mammalian ARF GTPases are activated by 15 differ-
ent guanine nucleotide exchange factors (GEFs) categorized 
in five classes. Among these, only seven GEFs can activate 
ARF1: three BFA-sensitive (GBF1, BIG1, and BIG2) and 
four SecinH3-sensitive (cytohesins 1–4; D’Souza-Schorey 
and Chavrier, 2006; Donaldson and Jackson, 2011). Both 
BFA- and SecinH3-sensitive GEFs share a common conserved 
SEC7 domain that promotes GDP release and subsequent GTP 
binding to ARF1. SecinH3-sensitive GEFs have in addition 
a pleckstrin homology domain that enables them to interact 
with phosphoinositides at the plasma membrane (Santy et al., 
1999; DiNitto et al., 2007).
We examined the effect of inhibition of several ARF1 
GEFs on the process of podosome formation (Fig. S3, B and 
D–G). We found that expression of dominant-negative mu-
tants of two BFA-sensitive GEFs, HA–BIG1 (E793K) and 
HA–BIG2 (E738K), did not prevent formation of podosomes 
in THP1 cells treated with TGFβ1 (Fig. S3, F and G, bottom). 
Conversely podosome formation was not affected by over-
expression of wild-type HA-BIG1 or HA-BIG2 (Fig. S3, F 
and G, top). Furthermore, both the wild-type HA-BIG1 and 
HA-BIG2 showed predominant Golgi localization (Fig. S3, 
F and G) and no podosome localization, consistent with pre-
vious studies (Citterio et al., 2006; Ishizaki et al., 2008). To 
inhibit the activity of the third BFA-sensitive GEF, GBF1, 
we used a small-molecule inhibitor, Golgicide A (Sáenz et 
al., 2009). We found only partial dissolution of podosomes 
in THP1 cells treated with TGFβ1 after application of Golgi-
cide A in a concentration that induced visible fragmentation 
of the Golgi complex (Fig. S3, B, D, and E). Thus, in spite 
of profound inhibitory effect of BFA on podosome formation, 
selective inhibition of the BFA-sensitive GEFs produced only 
minor effect on podosomes.
In contrast, knockdown of one of the SecinH3-sensitive 
GEFs, ARNO (cytohesin 2), significantly affected podosome 
formation in TGFβ1-activated (Fig. 4, A–D) or PMA-activated 
THP1 cells (Fig. S1, B, E, H, and I). Knockdown of ARNO led 
to a significant decrease in the number of podosomes per cell 
as well as the percentage of cells having more than 10 podo-
somes (Fig. 4, C and D). Additionally, we found that ARNO 
knockdown reduced ARF1 activity in THP1 cells stimulated by 
TGFβ1 (Fig. 4 E). Moreover, a dominant-negative mutant of 
ARNO (E156K) also suppressed podosome formation/main-
tenance (Fig.  4, F and G). The effect of ARNO knockdown 
on podosomes was specific, because knockdown of another 
SecinH3-sensitive GEF, cytohesin 1, did not inhibit podosome 
formation in stimulated THP1 cells (Fig. 4 B). Neither ARNO 
nor cytohesin 1 knockdown produced any significant effect on 
Golgi integrity (Fig. 4 B).
Next, we investigated the localization of ARNO and 
cytohesin 1 in TGFβ1-treated THP1 cells by expressing 
GFP-fusion construct of these GEFs. ARNO was found to 
localize to the rings surrounding the actin cores of podo-
somes (Fig. 5 A). Similarly, GFP-ARNO localized to the rim 
around the actin core of podosome rosettes (Fig. 5 B). More-
over, podosome-like structures formed by normal fibroblasts 
plated on RGD-functionalized lipid bilayers also contained 
ARNO in the rings surrounding the actin cores (Fig.  5  C). 
Live imaging of GFP-ARNO in all these situations revealed 
that ARNO localization at the podosome ring was stable 
and spanned the entire lifetime of a podosome (Fig.  5  D 
and Video 6). Unlike ARNO, cytohesin 1 showed diffuse lo-
calization over the plasma membrane and was not enriched 
at podosomes (Fig. 5 E).
Inhibition of ARF1 triggers podosome 
disassembly via activation of Rho  
and myosin-IIA
In search of downstream factors that mediate podosome disrup-
tion upon ARF1 inhibition, we checked the activity of three major 
Rho family G proteins in TGFβ1-treated THP1 cells. We found 
that the fraction of RhoA-GTP significantly increased upon in-
hibition of ARF1 by SecinH3 (Fig. 6 A), whereas activities of 
both Rac1 and Cdc42 did not change (Fig. 6, B and C). RhoA 
and Rho-associated kinase (ROCK) are master regulators of my-
osin-IIA–driven cell contractility, because ROCK-mediated acti-
vation of myosin regulatory light chain (MRLC) phosphorylation 
promotes assembly of myosin-II filaments as well as myosin-II 
motor activity (Vicente-Manzanares et al., 2009). Indeed, we have 
demonstrated that inhibition of ARF1 by SecinH3 promoted as-
sembly of the myosin-II filaments as visualized by live imaging 
of GFP-MRLC using SIM (Fig. 6 D and Video 7). Simultaneous 
visualization of podosomes and myosin-II filaments revealed that 
podosome disappearance occurred in those cell regions enriched 
in myosin-II filaments (Fig.  6  D), suggesting that podosome 
disassembly is triggered by local activation of myosin-II–driven 
contractility. Indeed, treatment of ARF1-inhibited cells lacking 
a majority of podosomes with an inhibitor of ROCK, Y-27632, 
led to a burst of podosome formation concurrent with the dis-
appearance of myosin-II filaments (Fig. 6 E and Video 8). To 
confirm that inhibition of ARF1 led to podosome disruption via 
activation of myosin-II filament assembly, we performed siRNA- 
mediated myosin-IIA heavy chain (MYH9) knockdown, which 
completely blocked formation of myosin-IIA filaments as visu-
alized by antibody to nonmuscle (NM) myosin heavy chain IIA 
(Fig. 6, F–H). Myosin-II knockdown by itself did not affect po-
dosome integrity (Fig. 6, F, I, K, and L). Although treatment of 
THP1 cells transfected with control siRNA by SecinH3 led to 
pronounced disassembly of podosomes (Fig. 6, G, K, and L), the 
same treatment on myosin-IIA knockdown cells did not disrupt 
podosomes (Fig. 6, J, K, and L).
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Constitutively active ARF1 induces actin-
rich puncta in fibroblasts
To test whether constitutively active ARF1 could induce for-
mation of podosome-like adhesions in a more general context, 
we expressed constitutively active ARF1, CFP–ARF1 (Q71L), 
in cells that normally do not form podosomes, such as MEFs. 
Overexpression of constitutively active but not wild-type ARF1 
induced formation of numerous actin-rich puncta localized to 
the ventral surface of these cells, in the same focal plane as focal 
adhesions (Fig. 7, A and B). Similar to mature podosomes, the 
actin-rich puncta induced by constitutively active ARF1 (CFP–
ARF1 Q71L) were transiently associated with CFP–ARF1 
(Q71L)–containing vesicles (Fig. 7 B, right). Formation of these 
puncta was accompanied by some reduction in the number of 
stress fibers and focal adhesions, but even total disassembly of 
these structures upon expression of dominant-negative RhoA 
(GFP–RhoA T19N) was not sufficient to induce actin-contain-
ing puncta (Fig. 7 C). At the same time, constitutively active 
ARF1 efficiently triggered formation of such puncta in cells 
also expressing dominant-negative RhoA (Fig. 7 D). Similarly, 
inhibition of Rho activity by cell-permeable C3 transferase 
(2 µg/ml) did not by itself induce formation of the actin puncta 
and did not interfere with the induction of these puncta by con-
stitutively active ARF1 (Fig. S5, D and E).
Proteins typically associated with podosome cores 
in different cell types (WIP, N-WASP, cortactin, Arp3, and 
dynamin-2) were found in the actin-rich puncta (Fig. S5, F–J). 
At the same time, protein components of the podosome ring, 
such as vinculin (unpublished data) and paxillin (Fig. S5 K), 
were not found to be associated with active ARF1-induced actin 
puncta, suggesting incomplete podosome formation. ARF1-in-
duced actin puncta were not related to clathrin-depended 
endocytic activity because they did not colocalize with clath-
rin-coated pits (Fig. S5 L).
Unlike native podosomes, the puncta induced by constitu-
tively active ARF1 were motile. Although podosomes of THP1 
cells (Fig. S4 D, right insets), as well as podosome-like struc-
tures in fibroblasts plated on fluid substrate (Yu et al., 2013), 
are essentially stationary with respect to the substratum, the po-
sitions of puncta induced by active ARF1 are oscillating, with 
a mean velocity of 0.88 ± 0.28 µm/s (± SD). Thus, constitu-
tively active ARF1 induced formation of actin-rich puncta in 
proximity to the ventral cell membrane that can be considered 
as incompletely anchored podosome-like structures and possi-
bly podosome precursors.
In spite of the difference between authentic podosomes 
and the actin-rich puncta induced by constitutively active ARF1, 
the puncta mimic one important podosome function, namely 
Figure 4. Knockdown of ARF1 exchange 
factor ARNO (cytohesin 2), but not cyto-
hesin 1, leads to podosome disruption. (A) 
Western blot showing ARNO and cytohesin 
1 levels in cells treated with control (scram-
bled) siRNA, ARNO, or cytohesin 1 siRNAs; 
α-tubulin was used as a loading control. (B, 
top) TGFβ1-stimulated THP1 cells transfected 
with scrambled siRNAs; podosomes labeled 
with phalloidin and Golgi apparatus labeled 
by antibody against GM130. (middle) siR-
NA-mediated knockdown of ARNO disrupted 
podosomes, leaving the Golgi undisturbed. 
(bottom) Cytohesin 1 knockdown disrupted 
neither podosomes nor Golgi. Bars, 5 µm. (C 
and D) Quantification of the effect of ARNO 
and cytohesin 1 knockdown on number of po-
dosomes per cell (C) and percentage of cells 
with more than 10 podosomes (D). (E) G-LISA 
quantification of ARF1-GTP level in nontrans-
fected TGFβ1-stimulated THP1 cells (control), 
scrambled siRNA–transfected cells, and cells 
transfected with ARNO siRNA. Mean ± SD is 
indicated. (F and G) Quantification of the ef-
fect of expression of wild-type GFP-ARNO and 
dominant-negative ARNO mutant (GFP–ARNO 
E156K) on mean number of podosomes per 
cell (F) and percentage of cells with more than 
10 podosomes (G). The data in C, D, F, and 
G are presented as indicated in the legend to 
Fig. 1. Pooled data of three independent ex-
periments are presented for each group. The 
significance of the difference between groups 
was estimated by two-tailed Student’s t test. 
ns, P > 0.05 (nonsignificant); **, P ≤ 0.01; 
***, P ≤ 0.001; ****, P ≤ 0.0001. o
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Figure 5. ARNO but not cytohesin 1 is localized to podosomes and podosome-like structures in different cell types. (A–C) Localization of F-actin marker, 
mCherry-UtrCH, and GFP-ARNO in TGFβ1-stimulated THP1 cell (A), active Src-transformed fibroblast (B), and fibroblast on a RGD-functionalized fluid lipid 
bilayer (C). Left, F-actin cores of podosomes (A), podosome rosettes (B), and podosome-like structures formed on fluid bilayer (C). (middle) GFP-ARNO 
localized to periphery of F-actin cores (A–C). (right) Merged images. The boxed areas (A and C: 2.5 × 2.5 µm2, bar, 1 µm; B: 14 × 14 µm2, bar, 5 µm) 
of merged images are enlarged and line scanned as shown in inset. The graphs on the right demonstrate intensity profiles of F-actin and ARNO in individ-
ual podosome (A), podosome rosette (B), and podosome-like structure on bilayer (C). (D) Time course of ARNO localization to the podosome periphery. 
Dynamics of F-actin (labeled by mCherry-UtrCH) and GFP-ARNO fluorescence intensities in the podosome shown in the boxed area (3 × 3 µm2) in the 
left panel are presented in the sequences in the right panels. Time interval between frames is 30 s. See also Video 6. (E) Cytohesin-1 is not localized to 
podosomes. (left) F-actin cores of podosomes in TGFβ1-stimulated THP1 cell. Middle, GFP–cytohesin 1 localization in the same cell. (right) Merged image. 
Line scanning through the individual podosome in the boxed area (4 × 1.5 µm2) of the merged image shown in inset is quantified in the graph on the right. 
No enrichment of GFP–cytohesin 1 at podosome core or periphery was detected. Bars, 5 µm.
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Figure 6. Inhibition of ARF1 activity induces RhoA activation. (A–C) 1-h incubation of TGFβ1-stimulated THP1 cells with 30 µM SecinH3 led to increase in 
RhoA-GTP (A) but not Rac1-GTP (B) or Cdc42-GTP (C) fractions as indicated by Western blots after pull-down assay. (D–J) SIM visualization of podosome 
dynamics in TGFβ1-stimulated THP1. (D and E) Live imaging of cell stably transfected with GFP-MRLC to visualize myosin-II filaments and RFP-Lifeact to visu-
alize podosome cores. (D) Cell treated with 30 µM SecinH3 shows an increase in myosin-IIA filament assembly (green) and disruption of podosomes (red). 
Enlarged image of white-boxed area (5 × 4.5 µm2) of D shows colocalization between appearance of myosin-IIA filaments and podosome disruption (see 
Video 7). (E) Time course of podosome reappearance after addition of 30 µM ROCK inhibitor Y-27632 to cell incubated in SecinH3-containing medium. 
Note that podosomes (red) appeared after disassembly of myosin-II filaments (green). (F–J) TGFβ1-stimulated THP1 cells were transfected with either control 
scrambled siRNA (F and G) or with siRNA to NM-myosin-IIA heavy chain, MYH9 (I and J) and, after 48 h, treated with either 0.1% DMSO (F and I) or 
30 µM SecinH3 (G and J) for 1 h. (F, G, I, and J) After fixation, the cells were stained with phalloidin (left) and antibodies to NM-myosin-IIA heavy chain 
(middle) and vinculin (right). Bars, 5 µm. (H) Western blot showing protein levels of NM-myosin-IIA heavy chain in control cells (transfected with scrambled 
siRNA) or in NM-myosin-IIA knockdown cells (transfected with MYH9 siRNA); α-tubulin was used as a loading control. (K and L) Effect of SecinH3 treatment 
of control and NM-myosin-IIA knockdown cells on number of podosomes per cell (K) and percentage of cells with more than 10 podosomes (L). The data 
in K and L are presented as indicated in the legend to Fig. 1. Pooled data of at least two independent experiments are presented for each group. The 
significance of the difference between groups was estimated by two-tailed Student’s t test. nonsignificant (ns), P > 0.05; ***, P ≤ 0.001.
o
n
 February 22, 2017
D
ow
nloaded from
 
Published December 22, 2016
ArNo-ArF1 signaling controls podosome formation • rafiq et al. 191
Figure 7. Constitutively active ARF1 induces F-actin–rich puncta (labeled by mCherry-UtrCH) in mouse fibroblasts. (A) Transfection with wild-type CFP-ARF1 
did not change actin cytoskeleton of fibroblast. (B) Numerous F-actin–rich puncta in the fibroblast transfected with constitutively active ARF1 mutant, CFP–
ARF1 Q71L. (B, right) Images of the boxed area (6 × 4.5 µm2) in the left panel showing F-actin (red, top row), CFP–ARF1 Q71L (green, middle row), and 
their superimposition (bottom row) at three time points taken with a 3-s time interval. Transient contacts (yellow) of CFP–ARF1 Q71L–containing puncta with 
the F-actin–rich puncta are seen. (C) Cell transfected with dominant-negative RhoA (GFP–RhoA T19N) did not contain stress fibers. (D) Cell cotransfected 
with dominant-negative RhoA (GFP–RhoA T19N) and constitutively active ARF1 (CFP–ARF1 Q71L) formed numerous F-actin–rich puncta. (E) Control fibro-
blast forming stress fibers (left) did not demonstrate localization of mCherry-WIP (right). (F) F-actin–rich puncta in fibroblast expressing CFP–ARF1 Q71L are 
enriched with mCherry-WIP. (G and H) Fibroblasts transfected with constitutively active ARF1 (CFP–ARF1 Q71L) were plated on fluorescent gelatin-coated 
coverslips in control medium containing 0.2% DMSO (G) or in medium containing 25 µM MMP inhibitor GM6001 (H) and incubated for 4 h. The matrix 
degradation sites in the boxed areas are seen at high magnification on the left in the bottom panels of G but not H. Actin puncta were visualized by 
phalloidin staining. High magnifications of boxed areas in G and H as well as merged images of actin and fluorescent gelatin are shown at left, middle, 
and right in the bottom panels of G and H, respectively. Note that actin puncta colocalize with dark areas corresponding to degraded fluorescent gelatin 
in control fibroblasts (G, bottom, white arrowheads), whereas gelatin degradation is completely prevented in cells treated with GM6001 (H, bottom). 
Bars: (A and C–H) 5 µm; (B) 1 µm.
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MMP-dependent ability to degrade the matrix. Indeed, the posi-
tions of actin puncta induced in the fibroblasts by constitutively 
active ARF1 (Q71L) coincided with the sites of matrix degrada-
tion: dark areas on the substratum covered with fluorescently la-
beled gelatin (Fig. 7 G). Formation of such dark areas could be 
prevented by treatment with 25 µM of MMP inhibitor GM6001 
(Fig. 7 H) and therefore depended on the exocytosis of MMPs 
by cells. Thus, our experiments show that actin puncta induced 
in fibroblasts by constitutively active ARF1 trigger local matrix 
degradation by facilitating exocytosis of MMPs, independently 
of podosome ring assembly.
Discussion
In this article, we demonstrate that an ARNO-ARF1 signal-
ing axis is required for the maintenance of podosome integrity 
(see Fig. 8 for flow diagram). First, knockdown of ARF1 but 
not ARF6 prevents podosome formation by TGFβ1- or PMA-
treated THP1 cells. In addition to these classic podosomes, 
we explored podosome-like structures induced in fibroblasts 
by either expression of constitutively active Src (Tarone et al., 
1985) or plating cells on a fluid substratum (Yu et al., 2013). We 
checked that specific drugs inhibiting ARF1-activating GEFs, 
BFA (Yamaji et al., 2000; Niu et al., 2005) and SecinH3 (Hafner 
et al., 2006), led to rapid dissolution of podosomes in THP1 
cells and the podosome-like structures in fibroblasts. In addi-
tion, we have shown that in both THP1 cells and fibroblasts, 
treatments inducing podosome formation augmented the frac-
tion of active, GTP-bound ARF1.
BFA and SecinH3 inhibit different classes of ARF1- 
activating GEFs (Donaldson and Jackson, 2011). In our ex-
periments, the BFA-sensitive GEFs (GBF1, BIG1, and BIG2) 
appeared to be functionally unrelated to podosome regulation. 
The inhibitory effect of BFA could thus be explained by seques-
tration of ARF1 within the BFA-induced ternary complexes 
consisting of inhibited GEFs, ARF1-GDP and BFA (Peyroche et 
al., 1999; Mossessova et al., 2003; Zeghouf et al., 2005). At the 
same time, we found that one of the SecinH3-sensitive GEFs, 
ARNO (cytohesin 2), but not cytohesin 1, is indispensable for 
podosome integrity in THP1 cells. Possible functions of several 
other ubiquitous ARF family proteins (ARF3, ARF4, and ARF5) 
as well as other SecinH3-sensitive GEFs, cytohesin 3 and 4, 
remain to be studied in the context of podosome formation.
Localization studies revealed that ARNO (but not cy-
tohesin 1) is stably colocalized with adhesion proteins in the 
ring domain of podosomes in THP1 cells as well as with podo-
some-like structures in fibroblasts. This is consistent with bio-
chemical data showing direct association of ARNO with paxillin 
(Torii et al., 2010). Furthermore, live-cell imaging showed tran-
sient contacts of vesicles containing ARF1 with the periphery 
and ring domain of podosomes and podosome-like structures 
in THP1 cells. We demonstrated that ARF1-containing vesicles 
are moving along microtubules, so one of the functions of mi-
crotubules important for podosome maintenance (Linder et al., 
2000) could be delivery of ARF1. It is worth noting that a neg-
ative regulator of ARF1 activity, ARF1 GTPase-activating pro-
tein ASAP1, was also shown to localize to podosomes (Shiba 
and Randazzo, 2011; Curtis et al., 2015).
How could active ARF1 affect podosome assembly and 
stability? The first possibility is based on well-documented 
functions of ARF1 in the Golgi complex and vesicular traffic 
(Donaldson et al., 2005). It can be conjectured that some of the 
ARF1-dependent functions of the Golgi are required for podo-
some integrity. This possibility cannot be entirely excluded; 
however, it is worth noting that in our experiments integrity of 
podosomes can be dissected from the integrity of the Golgi. In 
particular, inhibition of the ARF1 exchange factor GBF1, re-
sponsible for ARF1-dependent COPI recruitment to the Golgi, 
as well as knockdown of the COPI subunit, βCOP, only margin-
ally affected podosome integrity. ARF1 in principle could be 
involved in integrin turnover and affect podosome formation via 
regulation of available integrin adhesion receptors. However, in 
our experiment, experimental manipulations with ARF1 did not 
affect the integrity or dynamics of another class of integrin-de-
pendent adhesions, focal adhesions. This suggests that other 
mechanisms should be considered to explain the specific effect 
of ARF1 depletion/inhibition on podosome integrity.
Podosomes are part of the actin cytoskeleton and as such 
likely to be regulated by small G proteins of Rho family. We have 
shown that inhibition of ARF1 triggered significant activation of 
RhoA but not Rac or Cdc42. Activation of RhoA in turn triggers 
the assembly of numerous myosin-IIA filaments, which as we 
have demonstrated led to considerable disruption of podosomes. 
We have shown that suppression of myosin-IIA filament forma-
tion by either inhibition of ROCK or knockdown of myosin-IIA 
prevented the disruptive effect of ARF1 inhibition on podosome 
formation. Thus, our experiments suggest that ARF1 functions 
in podosome formation as an inhibitor of RhoA activity and 
Figure 8. Flow diagram illustrating the role of ARNO-ARF1 signaling axis 
in podosome formation. A variety of external factors known to switch cells 
toward podosome formation activate the ARF GEF, ARNO. ARNO acti-
vates ARF1, which in turn induces two major pathways regulating the po-
dosomes. First, ARF1 inhibits Rho, which negatively regulates podosomes 
via ROCK-dependent formation of myosin-II filaments. Second, ARF1 pro-
motes formation of Arp2/3- and actin-enriched podosome core-like struc-
tures associated with matrix degradation sites. The solid arrows represent 
the direct pathways, and the dashed arrows indicate the existence of un-
known intermediate steps in the depicted pathways.
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subsequent myosin-IIA filament formation. This conclusion is 
consistent with our observation that ARF1-dependent activation 
of podosome formation by plating of cells on fluid bilayer led 
to inhibition of RhoA (Yu et al., 2013).
Interestingly, apparently the same mechanism based on 
suppression of Rho and myosin-II by the cytohesin family ex-
change factor, Steppke, and a Drosophila melanogaster ARF 
was found in a completely different system, during cellulariza-
tion of Drosophila embryos (Lee and Harris, 2013). However, 
the pathway connecting ARF1 and RhoA remains unknown. 
It is perhaps worth noting that ARF1 can bind the RhoGAP 
ARH GAP10/21 and deliver it to the Golgi or plasma membrane 
(Dubois et al., 2005; Ménétrey et al., 2007; Kumari and Mayor, 
2008). ARH GAP10/21 is known to inhibit Cdc42 but also shows 
some RhoA inhibitory activity in vitro (Dubois et al., 2005).
It is also not clear why an excess of myosin-II filaments 
antagonizes podosome integrity. Myosin-II has been shown 
to localize to actin links radiating from the podosomes (van 
den Dries et al., 2013), but its functional role in podosomes 
is yet to be established.
In addition to its function as a myosin-II regulator, ARF1 
could affect podosomes via regulation of actin polymerization. 
There are several lines of evidence suggesting involvement of 
ARF1 in the regulation of Arp2/3 complex-driven actin polym-
erization: via recruitment of actin nucleation promoting WAVE 
complex (Humphreys et al., 2012a,b); via sequestration and in-
activation of Arp2/3 inhibitor, PICK1 (Rocca et al., 2013); and 
via activation of Cdc42 (Dubois et al., 2005; Heuvingh et al., 
2007). We were not able to find evidence of any of these mecha-
nisms in the context of podosome regulation. Neither data from 
the literature nor our own observations indicate that WAVE or 
PICK1 is localized to podosomes. Moreover, ARF1 inhibition 
did not induce any changes in GTP-bound Cdc42 levels, and 
constitutively active Cdc42 did not prevent or overcome the dis-
ruption of podosomes seen upon ARF1 inhibition.
Nevertheless, the effect of ARF1 on the polymerization 
of actin in the context of podosome formation is seen in our 
experiments with expression of constitutively active ARF1 
in fibroblast-type cells, which normally do not produce po-
dosomes. Active ARF1 not only suppresses stress fiber for-
mation, but also induces formation of numerous actin and 
Arp3-containing patches in such cells. The induction of actin 
polymerization at the plasma membrane by active ARF1 and 
ARF6 was previously demonstrated (Caviston et al., 2014). 
Many actin-associated proteins typical of podosomes (N-WASP, 
WIP, cortactin, and dynamin-II) were also found in these puncta. 
Moreover, a hallmark of podosome function, the local gelatin 
matrix degradation by MMPs, appeared to be associated with 
these puncta. At the same time, the puncta were not surrounded 
by any podosome adhesive ring components. The recruitment 
of certain adhesion components such as paxillin was shown to 
require dynamic GTP/GDP turnover of ARF1 (Liu et al., 2002, 
2005). This may explain the lack of adhesive ring surrounding 
podosome core-like structures induced by constitutively active 
ARF1. Of note, our data show that matrix degrading and adhe-
sion functions could be dissected under conditions of induction 
of podosome precursors by constitutively active ARF1.
The pathways downstream of ARF1 underlying forma-
tion of these podosome precursors are not the same as Rho and 
myosin-II inhibitory activity of ARNO-ARF1 characterized ear-
lier, because expression of dominant-negative RhoA did not by 
itself induce formation of the actin-rich puncta in fibroblasts. We 
cannot exclude that local changes in Cdc42 activity may still play 
a role in this process (Heuvingh et al., 2007), even though ARF1 
did not affect the total level of Cdc42 activity in our experiments.
In summary, we demonstrate that the signaling axis 
ARNO-ARF1 plays a critical role in the control of podosome 
integrity and find that this pathway in macrophage-like cells 
operates via inhibition of RhoA and myosin-II activity. Other 
pathways found in fibroblasts downstream of active ARF1 in-
duce formation of F-actin–rich puncta resembling podosome 
actin cores that are not associated with the matrix adhesion com-
ponents but are involved in matrix degradation. These findings 
open new features of the processes of podosome formation and 
matrix degradation. Investigation of ARNO-ARF1 upstream and 
downstream pathways provides a rich source of future studies.
Materials and methods
Cell culture and transfection procedures
THP1 human monocytic leukemia cell line was obtained from Health 
Protection Agency Culture Collections and cultured using RPMI-1640 
supplemented with 10% heat-inactivated FBS and 50 µg/ml 2-mercap-
toethanol (Sigma-Aldrich) at 37°C and 5% CO2.
The suspended THP-1 cells were differentiated into adherent 
macrophage-like cells with either 1 ng/ml human recombinant cyto-
kine TGFβ1 (R&D Systems) or 50 nM PMA (Sigma-Aldrich) for 24 
or 48 h on fibronectin-coated glass substrates. No apparent difference 
between the phenotypes of cells stimulated for 24 or 48 h was detected. 
35-mm glass-bottomed dishes (81158; Ibidi) were coated with 1 µg/ml 
fibronectin (EMD Millipore) in PBS for 1–2 h at 37°C, washed with 
PBS twice, and incubated in complete medium before seeding of cells.
Cells were transiently transfected before stimulation with DNA 
plasmids using electroporation (Neon Transfection System; Thermo 
Fisher Scientific) in accordance with manufacturer’s instructions. Spe-
cifically, two pulses of 1,400 V for 20 ms were used.
For siRNA transfection, THP1 cells were treated with 100 nM 
ARF1 siRNA (L-011580-00-0005; GE Healthcare), 150 nM ARF6 
siRNA (L-004008-00-0005; GE Healthcare), 100 nM MYH9 siRNA 
(L-007668-00-000; GE Healthcare), or 100 nM COPB1 siRNA (L-
017940-00-0005; GE Healthcare). For control experiments, cells 
were transfected with 100–150 nM non-targeting control siRNA 
(D-001810-10; GE Healthcare) at a concentration similar to individ-
ual gene-targeted siRNAs.
For knockdown of ARF GEFs in THP1 cells, siRNA duplex 
5′-GCA AUG GGC AGG AAG AAGU-3′ (Oh and Santy, 2010) against 
human ARNO sequence and 5′-AUG GAG GAG GAC GAC AGC UAC-3′ 
(Sendide et al., 2005) against human cytohesin 1 with dT-dT over-
hangs were purchased from Sigma-Aldrich. For rescue experiments 
in Fig. 1 D, ARF1 siRNA–transfected THP1 cells were cotransfected 
with HA-ARF1 (bovine origin, nonsensitive to aforementioned ARF1 
siRNA) and fixed 48 h after plating on fibronectin.
Immortalized rptp-α+/+ MEFs (Su et al., 1999) were obtained 
from the Sheetz laboratory (Mechanobiology Institute, Singapore, Sin-
gapore). MEFs were cultured in high-glucose DMEM supplemented 
with 10% heat-inactivated fetal bovine serum (Gibco), 1% l-glutamine, 
and 100 IU/mg penicillin-streptomycin (Invitrogen) at 37°C and 5% 
CO2. MEFs were transiently electroporated with a single pulse of 1,400 
V for 20 ms. MEFs were seeded on either fibronectin-coated 35-mm 
Ibidi or 27-mm Iwaki glass-bottomed dishes for 24 h posttransfection. 
For plating on supported lipid bilayer membrane, transfected MEFs 
were seeded on six-well Nunc plastic dishes (Thermo Fisher Scientific) 
for 24 h posttransfection. These MEFs were then treated with trypsin 
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solution, TrypLE (Thermo Fisher Scientific), for 5 min and kept in sus-
pension for 15 min in complete medium to recover from trypsinization 
before seeding on supported lipid bilayer membrane.
Plasmids
mCherry-WIP and GFP-WASP were described in Vijayakumar et al. 
(2015); GFP–β-actin and mCherry-talin, in Cox et al. (2011). The 
following plasmids described in corresponding references were pro-
vided by the listed researchers. EGFP-ARNO (Santy et al., 1999) and 
EGFP-ARNO E156K (Hernández-Deviez et al., 2004), J.  Casanova 
(University of Virginia, Charlottesville, VA); EGFP–cytohesin 1 (Bour-
goin et al., 2002), S. Bourgoin (University of Laval, Quebec, Canada); 
ARF1-RFP (Hsu et al., 2010), N. Altan-Bonnet (National Institutes of 
Health, Bethesda, MD); GFP-vinculin and mCherry-vinculin, M. Da-
vidson (Florida State University, Tallahassee, FL); GFP-Paxillin and 
mApple-Paxillin (Kanchanawong et al., 2010), P.  Kanchanawong 
(Mechanobiology Institute, Singapore, Singapore); constitutively ac-
tive Src Y527F, K.  Kawauchi (Mechanobiology Institute, Singapore, 
Singapore); EGFP-Rab6A (Miserey-Lenkei et al., 2010), S.  Mise-
rey-Lenkei (Institut Curie, Paris, France); GFP–Mannosidase II (van 
Galen et al., 2014), V. Malhotra (Center of Genomic Regulation, Barce-
lona, Spain); mApple-Rab11A (verified in-house), V. Allan (University 
of Manchester, Manchester, England, UK); GFP–Dynamin II (Ochoa 
et al., 2000), P.  De Camilli (Yale University, New Haven, CT); and 
Myosin regulatory light chain–GFP, M. Dodding (King’s College Lon-
don, London, England, UK). All BIG constructs (HA-BIG1, HA-BIG2, 
HA–BIG1 E793K, and HA–BIG2 E738K; Ishizaki et al., 2008) were 
obtained from H. Shin (Kyoto University, Kyoto, Japan).
The following plasmids described were purchased from Ad-
dgene: ARF1-GFP (39554), ARF1-ECFP (11381), ARF1(T31N)-ECFP 
(11384), ARF1(Q71L)-ECFP (11385), HA-ARF1 (10830), GFP-
Rab11 (12674), mCherry UtrCH (26740), EMTB-mCherry (26742), 
GFP-RhoA (T19N; 12967), ARF6-CFP (11382), mCherry-Arp3 
(27682), mCherry-Cortactin (27676), mCherry–clathrin light chain 
(27680), dsRed-Rab7 (12661), GFP-Rab8A (31803), and EMTB (ens-
consin)-mCherry (26742).
Supported lipid bilayer membrane
Methodologies of supported lipid bilayer preparation and membrane 
functionalization have been described in Yu et al. (2011) and Yu et al. 
(2013). In brief, 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) 
and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(cap bi-
otinyl) 16:0 (biotinyl-Cap-PE) were purchased from Avanti Polar 
Lipids, Inc. The lipids (0.2 mol% biotinyl-Cap-PE and 99.8 mol% 
DOPC) were mixed with an equal volume of PBS and pipetted onto 
cleaned glass substratum with a 25-mm coverslip placed on top for 
self-assembly of lipid vesicles. The lipid-coated coverslips were im-
mersed into a deionized water bath and then placed and sealed in an 
Attofluor cell chamber (Thermo Fisher Scientific). The supported lipid 
bilayer membrane ensemble was kept under aqueous environment at 
all times. For membrane functionalization, the supported lipid mem-
brane was blocked with 50 µg/ml Casein. A total of 0.1 µg/ml Cascade 
blue neutravidin (Thermo Fisher Scientific) was added onto supported 
lipid membranes, followed by 1 µg/ml biotinylated RGD, cyclo (Arg-
Gly-Asp-d-Phe-Lys [Biotin-PEG-PEG]) (Peptides International). Cells 
were then added onto the RGD-functionalized lipid bilayer membrane 
and imaged or fixed within 2–3 h of preparation.
Drug treatment
For drug inhibition studies, cells were treated with 30  µM SecinH3 
(Tocris Bioscience), 10 µM Golgicide A (Santa Cruz Biotechnology, 
Inc.), 5 µg/ml BFA (Sigma-Aldrich), 30 µM Y-27632 (Sigma-Aldrich), 
25 µM GM6001 (Enzo Life Sciences), and 2 µg/ml C3 transferase (Cy-
toskeleton, Inc.) in complete medium for 1–2 h or 4 h for GM6001 at 
37°C with 5% CO2 and subsequently fixed with 4% PFA. For live-cell 
imaging, cells were imaged immediately after addition of appropriate 
inhibitors, which remained in the medium during the entire period 
of image acquisition. To study the effect of inhibitors on podosomes 
formed by MEFs plated on RGD lipid bilayer, the cells were treated 
with appropriate inhibitors 30–45 min after cell seeding on the bilayer.
Immunoblotting
For verification of knockdown experiments, cells were lysed in RIPA buf-
fer 48 h after transfection. Extracted proteins were separated by 4–20% 
SDS-PAGE (Thermo Fisher Scientific), transferred to PVDF membranes 
(Bio-Rad Laboratories), incubated at 75 V for 2 h, and blocked for 1 h 
with 5% nonfat milk (Bio-Rad Laboratories) or BSA (Sigma-Aldrich). 
The PVDF membranes were incubated overnight at 4°C with appropriate 
antibodies: anti-ARF1 (dilution 1:1,000; ab108347; Abcam); anti-ARF6 
(dilution 1:1,000; ab77581; Abcam); anti-ARNO (dilution 1:1,000; 
ab56510; Abcam); anti–cytohesin 1 (dilution 1:500; MABT14; EMD 
Millipore); anti–α-tubulin (dilution 1:3,000; T6199; Sigma-Aldrich); an-
ti-βCOP (dilution 1:1,000; ab2899; Abcam); anti-HA (dilution 1:1,000; 
2367; Cell Signaling Technology); anti-Cdc42 (dilution 1:1,000; 2462; 
Cell Signaling Technology); anti-RhoA (dilution 1:1,000; sc-418; Santa 
Cruz Biotechnology, Inc.); anti-Rac1 (dilution 1:1,000; 610650; BD); 
and anti–NM myosin-IIA (dilution 1:1,000; M8064; Sigma-Aldrich).
After three washes (10 min each), appropriate secondary anti-
bodies conjugated with HRP (Bio-Rad Laboratories) were incubated 
with the membrane for 1 h, washed three times (15 min at RT), and de-
tected by ECL Western blotting substratum (Thermo Fisher Scientific) 
using CL-Xposure film (Thermo Fisher Scientific).
Small G protein activity assay
Total cell lysates were collected and immediately quantified by the 
G-LISA ARF1 or Cdc42 Activation Assay Biochem kit (colorimetric- 
based) and performed as per manufacturer’s protocol (Cytoskeleton, 
Inc.). Samples were run in duplicates per sample, means were calcu-
lated, and values were normalized to the total ARF1 or Cdc42 levels 
detected by immunoblotting. For each set of experiments, data were 
normalized to TGFβ1-treated THP1 cells giving a fold-change value 
from 0 (minimum) to 1 (maximum). A pull-down assay using GST-
tagged RhoA-binding domain of Rhotekin was used to precipitate GTP-
bound RhoA, and GST-tagged Rac1/Cdc42-binding domain of PAK1 
(PBD) beads were used to precipitate GTP-bound Rac1 or Cdc42 in 
THP1 cells. Pulled-down RhoA, Rac1, and Cdc42 were immunoblotted 
using respective antibodies as described in the previous section.
Immunofluorescence
Cells were fixed with 3.7% PFA in PBS, washed twice, permeabi-
lized with 0.5% Triton X-100 (Sigma-Aldrich) in PBS for 10 min, 
and washed twice. Fixed cells were blocked with 5% BSA or 5% FBS 
for 1 h at RT or overnight at 4°C before incubation with appropriate 
primary antibodies: anti-GM130 (dilution 1:400; 610822; BD); an-
ti-GRA SP65 (dilution 1:500; ab30315; Abcam); anti-HA (dilution 
1:400; 2367; Cell Signaling Technology), anti-vinculin (dilution 1:400; 
V9131; Sigma-Aldrich); anti-ARF6 (dilution 1:200; ab77581; Abcam); 
anti-βCOP (dilution 1:200; ab2899; Abcam); and anti–NM myosin-IIA 
(dilution 1:800; M8064; Sigma-Aldrich). Cells were washed three 
times with PBS and incubated with Alexa Fluor–conjugated second-
ary antibodies (Thermo Fisher Scientific) for 1 h at RT followed by 
three washes in PBS. Actin staining was performed using Alexa Fluor 
488 Phalloidin (Thermo Fisher Scientific), Phalloidin-TRI TC (Sigma- 
Aldrich), or Alexa Fluor 647 Phalloidin (Thermo Fisher Scientific).
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Matrix degradation assay
50% sulfuric acid–washed coverslips were coated with 50 mg/ml po-
ly-d-lysine for 30 min at RT and fixed with 0.5% glutaraldehyde for 
15 min. 0.2% gelatin warmed at 37°C was mixed with Oregon green 
488–conjugated pig gelatin at a 6:1 ratio. Coverslips were coated 
with gelatin mix for 10 min, washed with 1× PBS, and quenched 
with 5 mg/ml sodium borohydride for 15 min followed by numerous 
washes. For the matrix degradation assay, MEFs were seeded on these 
coated coverslips for 4 h and fixed for immunofluorescence imaging as 
described earlier. Dark spots corresponding to areas of cells indicate 
degradation of the matrix.
Live-cell imaging and microscopy
Cells were imaged in complete medium (unless stated otherwise) at an 
acquisition rate from 5-s to 1-min intervals using a spinning-disc con-
focal microscope (Ultraview VoX; PerkinElmer) attached to an inverted 
microscope (IX81; Olympus), equipped with a 100× oil-immersion 
objective (1.40 NA, UPlanSApo), an EMC CD camera (C9100-13; 
Hamamatsu Photonics) for image acquisition, and Volocity software 
(PerkinElmer) to control the acquisition protocol. Fixed samples and 
live cells were also imaged with a Nikon confocal A1R system and 
Nikon SIM attached to a Ti-E inverted microscope (Nikon) with Perfect 
Focus System using a 100× oil immersion objective (1.40 NA, CFI 
Plan-ApochromatVC). The cameras (Neo sCMOS and DU-897; Andor 
Technology) were used to acquire images for confocal A1R and SIM 
systems, respectively, with NIS-Elements AR software (Nikon) to con-
trol the acquisition protocol. For z-stack images, cells were imaged at a 
step size of 0.2–0.5 µm with a total height of 15–20 µm.
Image processing and data analysis
Image processing and analysis were performed with ImageJ or Volocity 
software. The number of podosomes (marked by core or ring marker) 
was quantified automatically using an ImageJ-based plugin for count-
ing nuclei, which was manually verified for the first 10 cells in the 
specimen to account for undetected podosomes (<10%). Line inten-
sity measurements (arbitrary units) of GFP-ARNO, GFP–Cytohesin 1, 
and mCherry-UtrCH were quantified by measuring the mean inten-
sity of GFP or mCherry fluorescence per area (square micrometers), 
background subtracted, and normalized with values ranging from 
0 (lowest) to 1 (highest).
Statistical analyses
Prism version 6 (GraphPad Software) was used to plot, analyze, and 
represent the data. Significance of the differences was determined using 
two-tailed unpaired Student’s t test or one-way analysis of variance for 
more than two groups. The methods for statistical analysis and sizes of 
the samples (n) are specified in Results or the figure legends for all of the 
quantitative data. Differences were accepted as significant for P < 0.05.
Online supplemental material
Fig. S1 shows that knockdown of either ARF1 or ARNO prevents forma-
tion of podosomes in THP1 cells stimulated by PMA, whereas ARF6 is 
not involved in podosome formation. Fig. S2 shows that ARF1-contain-
ing puncta are positive for Rab11 but not Rab6, Rab7, or Rab8. Fig. S3 
shows that inhibition of β-COP as well as ARF exchange factors GBF1, 
BIG1, and BIG2 does not lead to podosome disruption in TGFβ1-stim-
ulated THP1 cells, whereas the ARF1-mediated pathway of podosome 
formation does not involve Cdc42. Fig. S4 is a visualization of podo-
some dynamics in TGFβ1-stimulated THP1 cells stably transfected with 
GFP–β-actin (A, B, D, and E) and mCherry-talin by structured illumi-
nation microscopy. Fig. S5 shows that drugs reducing the level of GTP-
ARF1 disrupt podosome rosettes induced by constitutively active Src 
in fibroblasts, but do not disrupt focal adhesions. In addition, this figure 
shows formation of actin-rich puncta upon fibroblast transfection with 
constitutively active ARF1 and colocalization of podosome core pro-
teins to these puncta. Video 1 shows transient association of GFP-ARF1–
positive puncta and mCherry-vinculin–labeled podosomes as visualized 
by TIRF microscopy. Video 2 shows the movements of GFP-ARF1–
positive puncta along microtubules labeled by mCherry as visualized 
by spinning disk confocal microscopy. Video 3 shows that the disruption 
of podosomes labeled with mCherry-UtrCH in cells treated with 30 µM 
SecinH3 (left) is not accompanied by changes in Golgi apparatus mor-
phology and dynamics. Video 4 shows the dynamics of podosomes in 
control DMSO-treated cells labeled with GFP–β-actin as visualized by 
SIM. Video 5 shows the dynamics of podosomes labeled with GFP–β-
actin in cells treated with 30 µM SecinH3 as visualized by SIM. Video 6 
shows the dynamics of GFP-ARNO localization to podosome ring in the 
course of podosome formation and disassembly as visualized by spin-
ning disk confocal microscopy. Video 7 shows the burst of myosin II fil-
ament formation that accompanies podosome disruption in cells treated 
with 30 µM SecinH3 as visualized by SIM. Video 8 shows that the disas-
sembly of myosin II filaments by 30 µM Y-27632 results in recovery of 
podosomes in cells pretreated with 30 µM SecinH3 as visualized by SIM.
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